Anthony J. Brookes

Anthony J. Brookes

Auto-generated profile, based on publicly available information

Anthony J. Brookes

Department of Genetics and Genome Biology, University of Leicester, Leicester, UK

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2016 in Scientific Data
Verified
Journal Article
Open access
MWMark D. Wilkinson
Mark D. Wilkinson
MDMichel Dumontier
Michel Dumontier
IAIjsbrand Jan Aalbersberg
Ijsbrand Jan Aalbersberg
GAGabrielle Appleton
Gabrielle Appleton
MAMyles Axton
Myles Axton
BMBarend Mons
Barend Mons
There is an urgent need to improve the infrastructure supporting the reuse of scholarly data. A diverse set of stakeholders—representing academia, industry, funding agencies, and scholarly publishers—have come together to design and jointly endorse a concise and measureable set of principles that we refer to as the FAIR Data Principles. The intent is that these may act as a guideline for those wishing to enhance the reusability of their data holdings. Distinct from peer initiatives that focus on the human scholar, the FAIR Principles put specific emphasis on enhancing the ability of machines to automatically find and use the data, in addition to supporting its reuse by individuals. This Comment is the first formal publication of the FAIR Principles, and includes the rationale behind them, and some exemplar implementations in the community.

4 March 2019 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
MFMarc Fiume
Marc Fiume
MCMiroslav Cupak
Miroslav Cupak
SKStephen Keenan
Stephen Keenan
JRJordi Rambla
Jordi Rambla
STSabela de la Torre
Sabela de la Torre
SSSerena Scollen
Serena Scollen

1 June 2021 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
BZBirte Zurek
Birte Zurek
KEKornelia Ellwanger
Kornelia Ellwanger
LVLisenka E. L. M. Vissers
Lisenka E. L. M. Vissers
RSRebecca Schüle
Rebecca Schüle
MSMatthis Synofzik
Matthis Synofzik
HGHolm Graessner
Holm Graessner
For the first time in Europe hundreds of rare disease (RD) experts team up to actively share and jointly analyse existing patient’s data. Solve-RD is a Horizon 2020-supported EU flagship project bringing together >300 clinicians, scientists, and patient representatives of 51 sites from 15 countries. Solve-RD is built upon a core group of four European Reference Networks (ERNs; ERN-ITHACA, ERN-RND, ERN-Euro NMD, ERN-GENTURIS) which annually see more than 270,000 RD patients with respective pathologies. The main ambition is to solve unsolved rare diseases for which a molecular cause is not yet known. This is achieved through an innovative clinical research environment that introduces novel ways to organise expertise and data. Two major approaches are being pursued (i) massive data re-analysis of >19,000 unsolved rare disease patients and (ii) novel combined -omics approaches. The minimum requirement to be eligible for the analysis activities is an inconclusive exome that can be shared with controlled access. The first preliminary data re-analysis has already diagnosed 255 cases form 8393 exomes/genome datasets. This unprecedented degree of collaboration focused on sharing of data and expertise shall identify many new disease genes and enable diagnosis of many so far undiagnosed patients from all over Europe.

17 January 2025 in Nature Medicine
Verified
Journal Article
Open access
PDF file
SLSteven Laurie
Steven Laurie
WSWouter Steyaert
Wouter Steyaert
EBElke de Boer
Elke de Boer
KPKiran Polavarapu
Kiran Polavarapu
NSNika Schuermans
Nika Schuermans
AHAlex Hoischen
Alex Hoischen
Genetic diagnosis of rare diseases requires accurate identification and interpretation of genomic variants. Clinical and molecular scientists from 37 expert centers across Europe created the Solve-Rare Diseases Consortium (Solve-RD) resource, encompassing clinical, pedigree and genomic rare-disease data (94.5% exomes, 5.5% genomes), and performed systematic reanalysis for 6,447 individuals (3,592 male, 2,855 female) with previously undiagnosed rare diseases from 6,004 families. We established a collaborative, two-level expert review infrastructure that allowed a genetic diagnosis in 506 (8.4%) families. Of 552 disease-causing variants identified, 464 (84.1%) were single-nucleotide variants or short insertions/deletions. These variants were either located in recently published novel disease genes (n = 67), recently reclassified in ClinVar (n = 187) or reclassified by consensus expert decision within Solve-RD (n = 210). Bespoke bioinformatics analyses identified the remaining 15.9% of causative variants (n = 88). Ad hoc expert review, parallel to the systematic reanalysis, diagnosed 249 (4.1%) additional families for an overall diagnostic yield of 12.6%. The infrastructure and collaborative networks set up by Solve-RD can serve as a blueprint for future further scalable international efforts. The resource is open to the global rare-disease community, allowing phenotype, variant and gene queries, as well as genome-wide discoveries.

8 April 2022 in Human Mutation
Verified
Journal Article
Open access
JRJordi Rambla
Jordi Rambla
MBMichael Baudis
Michael Baudis
RARoberto Ariosa
Roberto Ariosa
TBTim Beck
Tim Beck
LFLauren A. Fromont
Lauren A. Fromont
ABAnthony J. Brookes
Anthony J. Brookes
Beacon is a basic data discovery protocol issued by the Global Alliance for Genomics and Health (GA4GH). The main goal addressed by version 1 of the Beacon protocol was to test the feasibility of broadly sharing human genomic data, through providing simple “yes” or “no” responses to queries about the presence of a given variant in datasets hosted by Beacon providers. The popularity of this concept has fostered the design of a version 2, that better serves real‐world requirements and addresses the needs of clinical genomics research and healthcare, as assessed by several contributing projects and organizations. Particularly, rare disease genetics and cancer research will benefit from new case level and genomic variant level requests and the enabling of richer phenotype and clinical queries as well as support for fuzzy searches. Beacon is designed as a “lingua franca” to bridge data collections hosted in software solutions with different and rich interfaces. Beacon version 2 works alongside popular standards like Phenopackets, OMOP, or FHIR, allowing implementing consortia to return matches in beacon responses and provide a handover to their preferred data exchange format. The protocol is being explored by other research domains and is being tested in several international projects.

9 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
TBTim Beck
Tim Beck
TRThomas Rowlands
Thomas Rowlands
TSTom Shorter
Tom Shorter
ABAnthony J Brookes
Anthony J Brookes
The GWAS Central resource gathers and curates extensive summary-level genome-wide association study (GWAS) data and puts a range of user-friendly but powerful website tools for the comparison and visualisation of GWAS data at the fingertips of researchers. Through our continued efforts to harmonise and import data received from GWAS authors and consortia, and data sets actively collected from public sources, the database now contains over 72.5 million P-values for over 5000 studies testing over 7.4 million unique genetic markers investigating over 1700 unique phenotypes. Here, we describe an update to integrate this extensive data collection with mouse disease model data to support insights into the functional impact of human genetic variation. GWAS Central has expanded to include mouse gene–phenotype associations observed during mouse gene knockout screens. To allow similar cross-species phenotypes to be compared, terms from mammalian and human phenotype ontologies have been mapped. New interactive interfaces to find, correlate and view human and mouse genotype–phenotype associations are included in the website toolkit. Additionally, the integrated browser for interrogating multiple association data sets has been updated and a GA4GH Beacon API endpoint has been added for discovering variants tested in GWAS. The GWAS Central resource is accessible at https://www.gwascentral.org/.